{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:04:38Z","timestamp":1786115078675,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.prro.2026.06.001","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:23:53Z","timestamp":1781627033000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic Versus Therapeutic Sucralfate in Patients at High Risk for Radiation Esophagitis: Randomized Controlled Trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-3731","authenticated-orcid":false,"given":"Jacob Y.","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Assel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna Y.","family":"Gelblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Guttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie F.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"Reyngold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gewanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rimner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris A.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneeth","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tafadzwa","family":"Chaunzwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Billing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil P.","family":"Mankuzhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia D.","family":"Austria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narek","family":"Shaverdian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2026.06.001_bib0001","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2013.07.029","article-title":"Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: An individual patient data meta-analysis","volume":"87","author":"Palma","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.001_bib0002","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2026.06.001_bib0003","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.06.001_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13605","article-title":"National patterns in prescription opioid use and misuse among cancer survivors in the United States","volume":"3","author":"Jairam","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.prro.2026.06.001_bib0005","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jnci\/djz200","article-title":"Predicting persistent opioid use, abuse, and toxicity among cancer survivors","volume":"112","author":"Vitzthum","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2026.06.001_bib0006","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ijrobp.2016.11.022","article-title":"A randomized phase 2 trial of prophylactic manuka honey for the reduction of chemoradiation therapy-induced esophagitis during the treatment of lung cancer: Results of NRG oncology RTOG 1012","volume":"97","author":"Fogh","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.001_bib0007","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.prro.2026.06.001_bib0008","first-page":"181","article-title":"Effect of sucralfate on gastroesophageal reflux in esophagitis","volume":"32","author":"Elsborg","year":"1985","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.prro.2026.06.001_bib0009","first-page":"1335","article-title":"Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux","volume":"85","author":"Herrera","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.prro.2026.06.001_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/02841869409098377","article-title":"Oral sucralfate in acute radiation oesophagitis","volume":"33","author":"Sur","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2026.06.001_bib0011","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.prro.2026.06.001_bib0012","series-title":"emmeans: Estimated marginal means, aka least-squares means","author":"Lenth","year":"2022"},{"key":"10.1016\/j.prro.2026.06.001_bib0013","series-title":"R: A Language and Environment for Statistical Computing","year":"2021"},{"key":"10.1016\/j.prro.2026.06.001_bib0014","doi-asserted-by":"crossref","first-page":"570","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R J"},{"key":"10.1016\/j.prro.2026.06.001_bib0015","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"10.1016\/j.prro.2026.06.001_bib0016","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): An open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.06.001_bib0017","series-title":"Understanding the opioid overdose epidemic","year":"2025"},{"key":"10.1016\/j.prro.2026.06.001_bib0018","series-title":"Secretary Kennedy renews public health emergency declaration to address national opioid crisis","year":"2025"},{"key":"10.1016\/j.prro.2026.06.001_bib0019","series-title":"Sucralfate. AHFS patient medication information","year":"2021"},{"key":"10.1016\/j.prro.2026.06.001_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/00365529009091919","article-title":"Why does sucralfate improve healing in reflux esophagitis? The role of sucrose octasulfate","volume":"173","author":"Orlando","year":"1990","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.prro.2026.06.001_bib0021","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.1997.15.3.1239","article-title":"Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis","volume":"15","author":"McGinnis","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.06.001_bib0022","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ijrobp.2013.07.033","article-title":"Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: Retrospective analysis of 425 patients","volume":"87","author":"Topkan","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.06.001_bib0023","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.prro.2020.03.002","article-title":"Exploring the relationship of radiation dose exposed to the length of esophagus and weight loss in patients with lung cancer","volume":"10","author":"Han","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2026.06.001_bib0024","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.lungcan.2013.02.008","article-title":"The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801","volume":"80","author":"Lawrence","year":"2013","journal-title":"Lung Cancer"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026001906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026001906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:02:20Z","timestamp":1785974540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026001906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":24,"alternative-id":["S1879850026001906"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.06.001","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic Versus Therapeutic Sucralfate in Patients at High Risk for Radiation Esophagitis: Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}